Uchino Shigehiko, Cole Louise, Morimatsu Hiroshi, Goldsmith Donna, Bellomo Rinaldo
Department of Intensive Care and Medicine, University of Melbourne, and Austin & Repatriation Medical Centre Melbourne, Heidelberg, Victoria, Australia.
Intensive Care Med. 2002 Nov;28(11):1664-7. doi: 10.1007/s00134-002-1495-z.
To measure the sieving coefficient (SC) and clearance of vancomycin during high-volume haemofiltration (HVHF) and to evaluate the impact of different pre-dilution regimens on these variables.
Prospective interventional study in the intensive care unit in a tertiary university hospital.
Seven patients with septic shock and multi-organ dysfunction.
HVHF (6 l/h fluid exchange) was performed in septic shock patients using variable proportions of their replacement fluid in pre- and post-dilution mode.
Pre-filter, post-filter and ultrafiltrate vancomycin concentrations were measured simultaneously, and SC and clearance calculated. The measurements were repeated following each change in the proportion of pre-dilution fluid. SC steadily decreased as the proportion of pre-dilution decreased, changing from 0.76 in pure pre-dilution to 0.57 in pure post-dilution (p=0.0004). Clearance, however, increased with decreasing pre-dilution fluid rate, from 53.9 ml/min at pure pre-dilution to 67.2 ml/min at 2 l/h pre-dilution with 4 l/h post-dilution.
HVHF achieves high vancomycin clearances, which despite some deterioration in SC increase with the proportion of replacement fluid given post-filter. Clinicians applying HVHF need to be aware of such clearances to avoid inadequate vancomycin dosing and to adjust therapy according to variations in HVHF technique.
测定高容量血液滤过(HVHF)期间万古霉素的筛系数(SC)和清除率,并评估不同预稀释方案对这些变量的影响。
在一所三级大学医院的重症监护病房进行的前瞻性干预研究。
7例感染性休克和多器官功能障碍患者。
对感染性休克患者进行HVHF(液体交换速度为6 l/h),采用不同比例的置换液进行预稀释和后稀释模式。
同时测量滤器前、滤器后和超滤液中万古霉素的浓度,并计算SC和清除率。每次改变预稀释液比例后重复测量。随着预稀释比例的降低,SC稳步下降,从纯预稀释时的0.76降至纯后稀释时的0.57(p = 0.0004)。然而,清除率随着预稀释液流速的降低而增加,从纯预稀释时的53.9 ml/min增加到预稀释2 l/h、后稀释4 l/h时的67.2 ml/min。
HVHF可实现较高的万古霉素清除率,尽管SC有所下降,但随着滤器后给予的置换液比例增加而增加。应用HVHF的临床医生需要了解此类清除率,以避免万古霉素剂量不足,并根据HVHF技术的变化调整治疗方案。